Literature DB >> 23203506

Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan.

Shuu-Jiun Wang1, Po-Jen Wang, Jong-Ling Fuh, Kuan-Po Peng, Kwong Ng.   

Abstract

BACKGROUND: The International Burden of Migraine Study (IBMS) showed chronic migraine (CM) was associated with a higher disease burden than episodic migraine (EM). However, in this study Asians with CM were underrepresented. Objectives We investigated if CM and EM differed in headache-related disability, health-related quality of life (HRQoL) and health care resource utilization in Taiwan.
METHODS: This study recruited patients with EM and CM from two headache clinics in Taiwan. Diagnosis was made by physicians based on Silberstein-Lipton criteria. Participants completed a questionnaire including sociodemographics, Migraine Disability Assessment (MIDAS), EuroQol five-dimensions (EQ-5D), Migraine-Specific Quality of Life v2.1 (MSQ), Patient Health Questionnaire-4 (PHQ-4), productivity and health care resource utilization.
RESULTS: A total of 331 patients (EM, n = 164 (49.5%); CM, n = 167 (50.5%)) completed the study. CM patients reported a significantly higher MIDAS score, lower generic (EQ-5D visual analogue scale score and EQ-5D index score) and migraine-specific (all three domains of MSQ) HRQoL, higher levels of anxiety and depression (PHQ-4 ≥ 6) and greater health care resource utilization and productivity loss than those with EM. Positive correlations were found between these instruments and levels of anxiety and depression.
CONCLUSION: Compared to EM, CM was significantly associated with higher disability, lower HRQoL and greater health care resource utilization and productivity loss.

Entities:  

Mesh:

Year:  2012        PMID: 23203506     DOI: 10.1177/0333102412468668

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  31 in total

Review 1.  Economic burden and costs of chronic migraine.

Authors:  Michel Lanteri-Minet
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 2.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 3.  Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

Authors:  Claus M Escher; Lejla Paracka; Dirk Dressler; Katja Kollewe
Journal:  Ther Adv Neurol Disord       Date:  2016-11-16       Impact factor: 6.570

4.  Improving access to care for patients with migraine in a remote Pacific population.

Authors:  Virginia Baker; Nawaz Hack
Journal:  Neurol Clin Pract       Date:  2020-10

Review 5.  Sex Differences in Chronic Migraine: Focusing on Clinical Features, Pathophysiology, and Treatments.

Authors:  Chia-Kuang Tsai; Chia-Lin Tsai; Guan-Yu Lin; Fu-Chi Yang; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2022-02-26

6.  Efficacy and safety of erenumab in migraine prevention: evidences from direct and indirect comparisons.

Authors:  Xing Wang; Qiang He; Dingke Wen; Lu Ma; Chao You
Journal:  Neurol Sci       Date:  2021-11-03       Impact factor: 3.830

Review 7.  Update of Inpatient Treatment for Refractory Chronic Daily Headache.

Authors:  Tzu-Hsien Lai; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2016-01

8.  The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results.

Authors:  Aubrey Manack Adams; Daniel Serrano; Dawn C Buse; Michael L Reed; Valerie Marske; Kristina M Fanning; Richard B Lipton
Journal:  Cephalalgia       Date:  2014-10-10       Impact factor: 6.292

Review 9.  Neural Plasticity in Common Forms of Chronic Headaches.

Authors:  Tzu-Hsien Lai; Ekaterina Protsenko; Yu-Chen Cheng; Marco L Loggia; Gianluca Coppola; Wei-Ta Chen
Journal:  Neural Plast       Date:  2015-08-20       Impact factor: 3.599

10.  A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes.

Authors:  Stefano Palmisani; Adnan Al-Kaisy; Roberto Arcioni; Tom Smith; Andrea Negro; Giorgio Lambru; Vijay Bandikatla; Eleanor Carson; Paolo Martelletti
Journal:  J Headache Pain       Date:  2013-08-06       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.